D. M. Anderson, U.S. Patent No. 5,238,613 (issued 1993) and associated European Patent #0292145, "Microporous materials," based on the polymerization of lyotropic liquid crystals.
D.M. Anderson, U.S. Provisional Patent Application 61/674,068, “Counterion-depleted electret filters having spatially distributed permanently charged domains.”
D. M. Anderson, U.S. Patent No. 5,244,799 (issued 1993) "Preparation of polymeric hydrogel containing micropores and macropores."
D. M. Anderson, U.S. Provisional Patent Application USSN 61/624,430, “Coronary stents incorporating P2Y2 agonist”.
D. M. Anderson, U.S. Patent No. 7,713,440 (issued 2010) and associated European Patents currently in various stages of issuance, “Stabilized uncoated particles of reverse liquid crystalline phase materials.”
D. M. Anderson, U.S. Patent Application #20100316606, “Stabilized formulations of peptides and proteins”.
D. M. Anderson, V. M. Conklin and B. G. Cameransi, U.S. Patent 7,968,124 (issued 2011) “Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use”.
C. H. Wick and D. M. Anderson, U.S. Patent No. 6,051,189 (issued 2000) “System and method for detection, identification and monitoring of submicron particles”.
D. M. Anderson, U.S. Patent Nos. 6,482,517 (issued 2002), 6,638,621 (issued 2003), and U.S. 6,989,195, and associated international patents, “Coated particle and methods of making and using the same”. Continuations of this patent line include U.S. 6,989,195 and U.S. 7,105,229.
Many of these have foreign counterparts as well.